- Home
- SRL vs CYBN Comparison
SRL vs CYBN Comparison
Compare SRL & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- CYBN
- Stock Information
- Founded
- SRL 2017
- CYBN 2019
- Country
- SRL China
- CYBN Canada
- Employees
- SRL N/A
- CYBN N/A
- Industry
- SRL Professional Services
- CYBN Pharmaceuticals and Biotechnology
- Sector
- SRL Consumer Discretionary
- CYBN Health Care
- Exchange
- SRL Nasdaq
- CYBN Nasdaq
- Market Cap
- SRL 115.0M
- CYBN 127.3M
- IPO Year
- SRL N/A
- CYBN N/A
- Fundamental
- Price
- SRL $7.70
- CYBN $6.95
- Analyst Decision
- SRL
- CYBN Strong Buy
- Analyst Count
- SRL 0
- CYBN 4
- Target Price
- SRL N/A
- CYBN $86.00
- AVG Volume (30 Days)
- SRL 4.1K
- CYBN 313.9K
- Earning Date
- SRL 05-06-2025
- CYBN 06-25-2025
- Dividend Yield
- SRL 3.48%
- CYBN N/A
- EPS Growth
- SRL N/A
- CYBN N/A
- EPS
- SRL N/A
- CYBN N/A
- Revenue
- SRL $33,997,735.00
- CYBN N/A
- Revenue This Year
- SRL N/A
- CYBN N/A
- Revenue Next Year
- SRL N/A
- CYBN N/A
- P/E Ratio
- SRL N/A
- CYBN N/A
- Revenue Growth
- SRL N/A
- CYBN N/A
- 52 Week Low
- SRL $5.74
- CYBN $4.81
- 52 Week High
- SRL $9.99
- CYBN $14.44
- Technical
- Relative Strength Index (RSI)
- SRL 48.98
- CYBN 49.83
- Support Level
- SRL $7.45
- CYBN $6.83
- Resistance Level
- SRL $7.65
- CYBN $7.54
- Average True Range (ATR)
- SRL 0.32
- CYBN 0.65
- MACD
- SRL -0.01
- CYBN 0.13
- Stochastic Oscillator
- SRL 51.32
- CYBN 65.24
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.